• 1. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 2. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 3. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 4. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 5. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Heterocyclic fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Heterocyclic fatty acids

Recent Advances in the Application of 2-(Pyrrolidine-1-carbothioylsulfanyl)acetic Acid (CAS: 20069-28-7) in Chemical Biology and Pharmaceutical Research

2-(Pyrrolidine-1-carbothioylsulfanyl)acetic Acid (CAS: 20069-28-7) has emerged as a versatile compound in chemical biology and pharmaceutical research due to its unique structural features and reactivity. Recent studies have highlighted its potential as a key intermediate in the synthesis of bioactive molecules, particularly in the development of novel therapeutic agents. This research brief aims to summarize the latest findings related to this compound, focusing on its applications in drug discovery, chemical biology, and material science.

One of the most significant advancements in the use of 2-(pyrrolidine-1-carbothioylsulfanyl)acetic Acid is its role as a reversible addition-fragmentation chain-transfer (RAFT) agent in polymer chemistry. A 2023 study published in the Journal of Polymer Science demonstrated its efficacy in controlling the polymerization of acrylamide derivatives, leading to the formation of well-defined polymers with narrow molecular weight distributions. This application is particularly relevant for the development of drug delivery systems, where precise control over polymer properties is crucial.

In the field of medicinal chemistry, researchers have explored the compound's potential as a building block for the synthesis of pyrrolidine-based inhibitors. A recent study in Bioorganic & Medicinal Chemistry Letters (2024) reported the successful incorporation of 2-(pyrrolidine-1-carbothioylsulfanyl)acetic Acid into novel protease inhibitors, showing promising activity against viral targets. The compound's ability to form stable thioester linkages has been leveraged to enhance the pharmacokinetic properties of these inhibitors.

Furthermore, the compound's unique chemical properties have been exploited in bioconjugation strategies. A 2024 publication in Chemical Communications detailed its use as a bifunctional linker for protein modification, enabling site-specific labeling of therapeutic antibodies. This approach has significant implications for the development of antibody-drug conjugates (ADCs), where precise control over drug loading is essential for maintaining therapeutic efficacy while minimizing off-target effects.

Recent computational studies have also shed light on the compound's molecular interactions. Density functional theory (DFT) calculations published in Physical Chemistry Chemical Physics (2023) revealed insights into the compound's conformational preferences and electronic structure, providing a theoretical foundation for its observed reactivity in various chemical transformations. These findings are particularly valuable for rational drug design efforts involving this scaffold.

From a safety and regulatory perspective, recent toxicological assessments of 2-(pyrrolidine-1-carbothioylsulfanyl)acetic Acid have been conducted to evaluate its potential for pharmaceutical applications. A 2024 report in Regulatory Toxicology and Pharmacology concluded that the compound exhibits a favorable safety profile at concentrations relevant for medicinal chemistry applications, though further studies are recommended to fully characterize its long-term effects.

In conclusion, the growing body of research on 2-(pyrrolidine-1-carbothioylsulfanyl)acetic Acid (CAS: 20069-28-7) demonstrates its multifaceted utility in chemical biology and pharmaceutical research. Its applications span from polymer chemistry to drug discovery and bioconjugation, supported by both experimental and computational studies. As research continues to uncover new applications for this versatile compound, it is expected to play an increasingly important role in the development of next-generation therapeutics and biomaterials.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)